These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36244543)

  • 1. N-Acylethanolamine acid amidase (NAAA) exacerbates psoriasis inflammation by enhancing dendritic cell (DCs) maturation.
    Li Y; Li Y; Xu S; Chen Y; Zhou P; Hu T; Li H; Liu Y; Xu Y; Ren J; Qiu Y; Lu C
    Pharmacol Res; 2022 Nov; 185():106491. PubMed ID: 36244543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the discovery of N-acylethanolamine acid amidase inhibitors.
    Bandiera T; Ponzano S; Piomelli D
    Pharmacol Res; 2014 Aug; 86():11-7. PubMed ID: 24798679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
    Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
    Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215.
    Li Y; Zhou P; Chen H; Chen Q; Kuang X; Lu C; Ren J; Qiu Y
    Pharmacol Res; 2018 Jun; 132():7-14. PubMed ID: 29572189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAAA inhibitor F96 attenuates BBB disruption and secondary injury after traumatic brain injury (TBI).
    Li Y; Zhou P; Hu T; Ren J; Xu Y; Qiu Y; Lu C; Li Y
    Eur J Pharmacol; 2021 Dec; 912():174561. PubMed ID: 34655598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Acylethanolamine Acid Amidase contributes to disease progression in a mouse model of multiple sclerosis.
    Pontis S; Palese F; Summa M; Realini N; Lanfranco M; De Mei C; Piomelli D
    Pharmacol Res; 2020 Oct; 160():105064. PubMed ID: 32634582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
    Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D
    Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.
    Fiasella A; Nuzzi A; Summa M; Armirotti A; Tarozzo G; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
    ChemMedChem; 2014 Jul; 9(7):1602-14. PubMed ID: 24828120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Blockade of NAAA Cell-specifically Regulates Fatty Acid Ethanolamides (FAEs) Metabolism and Inflammatory Responses.
    Xie X; Li Y; Xu S; Zhou P; Yang L; Xu Y; Qiu Y; Yang Y; Li Y
    Front Pharmacol; 2021; 12():817603. PubMed ID: 35069223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.
    Fotio Y; Ciccocioppo R; Piomelli D
    Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Piomelli D; Scalvini L; Fotio Y; Lodola A; Spadoni G; Tarzia G; Mor M
    J Med Chem; 2020 Jul; 63(14):7475-7490. PubMed ID: 32191459
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.
    Ponzano S; Bertozzi F; Mengatto L; Dionisi M; Armirotti A; Romeo E; Berteotti A; Fiorelli C; Tarozzo G; Reggiani A; Duranti A; Tarzia G; Mor M; Cavalli A; Piomelli D; Bandiera T
    J Med Chem; 2013 Sep; 56(17):6917-34. PubMed ID: 23991897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
    Jin W; Yang L; Yi Z; Fang H; Chen W; Hong Z; Zhang Y; Zhang G; Li L
    Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32326173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.
    Petracca R; Ponzano S; Bertozzi SM; Sasso O; Piomelli D; Bandiera T; Bertozzi F
    Eur J Med Chem; 2017 Jan; 126():561-575. PubMed ID: 27915171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund's Adjuvant Rat Model of Arthritis.
    Bonezzi FT; Sasso O; Pontis S; Realini N; Romeo E; Ponzano S; Nuzzi A; Fiasella A; Bertozzi F; Piomelli D
    J Pharmacol Exp Ther; 2016 Mar; 356(3):656-63. PubMed ID: 26769918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis.
    Zhou P; Xiang L; Yang Y; Wu Y; Hu T; Liu X; Lin F; Xiu Y; Wu K; Lu C; Ren J; Qiu Y; Li Y
    Pharmacol Res; 2019 Jul; 145():104264. PubMed ID: 31063807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.
    Bottemanne P; Guillemot-Legris O; Paquot A; Masquelier J; Malamas M; Makriyannis A; Alhouayek M; Muccioli GG
    Neurotherapeutics; 2021 Jul; 18(3):1815-1833. PubMed ID: 34235639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
    Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C
    Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds.
    Li Y; Yang L; Chen L; Zhu C; Huang R; Zheng X; Qiu Y; Fu J
    PLoS One; 2012; 7(8):e43023. PubMed ID: 22916199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α.
    Yang L; Li L; Chen L; Li Y; Chen H; Li Y; Ji G; Lin D; Liu Z; Qiu Y
    Sci Rep; 2015 Aug; 5():13565. PubMed ID: 26310614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.